The recent launch of SearchGPT by OpenAI marks the beginning of a significant shift in how information is searched and consumed for pharma and healthcare industry leaders.
An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.
Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.
Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.
Editor's Picks
